The impact of time-window bias on the assessment of the long-term effect of medication adherence: the case of secondary prevention after myocardial infarction

被引:17
|
作者
Di Martino, Mirko [1 ]
Kirchmayer, Ursula [1 ]
Agabiti, Nera [1 ]
Bauleo, Lisa [1 ]
Fusco, Danilo [1 ]
Perucci, Carlo Alberto
Davoli, Marina [1 ]
机构
[1] Lazio Reg Hlth Serv, Dept Epidemiol, Rome, Italy
来源
BMJ OPEN | 2015年 / 5卷 / 06期
关键词
MORTALITY;
D O I
10.1136/bmjopen-2015-007866
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Objectives: Time-window bias was described in case-control studies and led to a biased estimate of drug effect. No studies have measured the impact of this bias on the assessment of the effect of medication adherence on health outcomes. Our goals were to estimate the association between adherence to drug therapies after myocardial infarction (MI) and the incidence of a new MI, and to quantify the error that would have been produced by a time-window bias. Setting: This is a population-based study. Data were obtained from the Regional Health Information Systems of the Lazio Region in Central Italy (around 5 million inhabitants). Participants: Patients discharged after MI in 2006-2007 were enrolled in the cohort and followed through 2009. Outcome measure: The study outcome was reinfarction: either mortality, or hospital admission for MI, whichever occurred first. Design: A nested case-control study was performed. Controls were selected using both time-dependent and time-independent sampling. Adherence to antiplatelets, a-blockers, ACE inhibitors/angiotensin receptor blockers (ACEI/ARBs) and statins was calculated using the proportion of days covered (PDC). Results: A total of 6880 patients were enrolled in the cohort. Using time-dependent sampling, a protective effect was detected for all study drugs. Conversely, using time-independent sampling, the beneficial effect was attenuated, as in the case of antiplatelet agents and statins, or completely masked, as in the case of ACEI/ARBs and a-blockers. For ACEI/ARBs, the time-dependent approach produced ORs of 0.83 (95% CI 0.57 to 1.21) and 0.72 (0.55 to 0.95), respectively, for '0.5<PDC <= 0.75' and 'PDC>0.75' versus '0 <= PDC <= 0.5'. Using the time-independent approach, the ORs were 0.96 (0.65 to 1.43) and 1.00 (0.76 to 1.33), respectively. Conclusions: A time-independent definition of a time-dependent exposure introduces a bias when the length of follow-up varies with the outcome. The persistence of time-related biases in peer-reviewed papers strongly suggests the need for increased awareness of this methodological pitfall.
引用
收藏
页数:7
相关论文
共 50 条
  • [41] Long-Term Variation in Kidney Function and Its Impact After Acute Myocardial Infarction
    Rodenas-Alesina, Eduard
    Cabeza-Martinez, Paolo
    Zamora-Putin, Valeria
    Pariggiano, Ivana
    Escalona, Roxana
    Belahnech, Yassin
    Delgado de la Cruz, Montse
    Calabro, Paolo
    Ferreira-Gonzalez, Ignacio
    Baneras, Jordi
    AMERICAN JOURNAL OF CARDIOLOGY, 2022, 163 : 20 - 24
  • [42] THE IMPACT OF THE CHANGE IN ANEMIA STATUS AFTER ACUTE MYOCARDIAL INFARCTION ON LONG-TERM PROGNOSIS
    Lee, Dongyoung
    Kim, Ji Bak
    Choi, Cheol Ung
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2022, 79 (09) : 1107 - 1107
  • [43] Long-Term Time-Varying Risk of Readmission After Acute Myocardial Infarction
    Khot, Umesh N.
    Johnson, Michael J.
    Wiggins, Newton B.
    Lowry, Ashley M.
    Rajeswaran, Jeevanantham
    Kapadia, Samir
    Menon, Venu
    Ellis, Stephen G.
    Goepfarth, Pamela
    Blackstone, Eugene H.
    JOURNAL OF THE AMERICAN HEART ASSOCIATION, 2018, 7 (21):
  • [44] Emotional Distress is a Predictor of Poor Long-Term Statin Adherence at Two Years After a Myocardial Infarction
    Lissaker, Claudia T.
    Wallert, John
    Held, Claes
    Olsson, Erik
    CIRCULATION, 2016, 134
  • [45] Adherence to beta-blockers and long-term risk of heart failure and mortality after a myocardial infarction
    Desta, Liyew
    Khedri, Masih
    Jernberg, Tomas
    Andel, Pontus
    Mohammad, Moman Aladdin
    Hofman-Bang, Claes
    Erlinge, David
    Spaak, Jonas
    Persson, Hans
    ESC HEART FAILURE, 2021, 8 (01): : 344 - 355
  • [46] Adherence to the treatment of patients in the long-term supervision period after myocardial infarction (according to the REGATA register)
    Pereverzeva, K. G.
    Yakushin, S. S.
    Luk'yanov, M. M.
    Drapkina, O. M.
    KARDIOLOGIYA, 2020, 60 (10) : 66 - 72
  • [47] Critical time-window for NO-cGMP-dependent long-term memory formation after one-trial appetitive conditioning
    Kemenes, I
    Kemenes, G
    Andrew, RJ
    Benjamin, PR
    O'Shea, M
    JOURNAL OF NEUROSCIENCE, 2002, 22 (04): : 1414 - 1425
  • [48] Adherence to Secondary Prevention Measures after Acute Myocardial Infarction and Its Impact on Patient Outcome-A Nationwide Perspective
    Hammer, Andreas
    Sinkovec, Hana
    Todorovic, Marko
    Katsch, Florian
    Gall, Walter
    Duftschmid, Georg
    Heinze, Georg
    Niessner, Alexander
    Sulzgruber, Patrick
    JOURNAL OF CLINICAL MEDICINE, 2024, 13 (16)
  • [49] Post-myocardial Infarction (MI) Care: Medication Adherence for Secondary Prevention After MI in a Large Real-world Population
    Huber, Carola A.
    Meyer, Matthias R.
    Steffel, Jan
    Blozik, Eva
    Reich, Oliver
    Rosemann, Thomas
    CLINICAL THERAPEUTICS, 2019, 41 (01) : 107 - 117
  • [50] Long-term Medication Adherence and Prognosis after Successful Percutaneous Coronary Intervention in Patients with Acute Myocardial Infarction: Experiences from the Korean Multicenter Registry
    Kim, Min Chul
    Sim, Doo Sun
    Hong, Young Joon
    Kim, Juhan
    Ahn, Youngkeun
    Jeong, Myung Ho
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2018, 72 (13) : B291 - B291